Peter Thompson is the founder of Terremoto Biosciences. Terremoto Biosciences has raised $250M in total funding. Latest round: Series B.
Peter Thompson is a co-founder, CEO, and board member of Terremoto Biosciences, a biotechnology company based in South San Francisco. Terremoto Biosciences focuses on discovering and developing groundbreaking covalent medicines using its lysine-based covalency platform. The company has raised a total of $250 million through Series A and Series B financing rounds, with investments from firms such as OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. He is also a general partner at OrbiMed.
Full founder directory · Investor directory · Company funding database · Fundraising library